-
Surgalign & NuVasive: How they line up in Q1
Medical technology companies Surgalign and NuVasive posted their first quarter financial results for 2023. -
2 devicemakers laying off staff
Medtronic and Stryker both have plans to lay off swaths of employees. -
Abbott's spinal cord stimulators earn additional FDA indications
Abbott's spinal cord stimulation devices earned FDA approval to address chronic back pain for patients who aren't eligible for spine surgery, the medtech company said May 16. -
Globus Medical earns FDA approval for non-fusion scoliosis system
Globus Medical recieved FDA aproval for its Reflect scoliosis correction system, the devicemaker said May 15. -
Waypoint Orthopedics earns FDA approval for spinal pedicle screw tool
Waypoint Orthopedics earned FDA approval for the Waypoint GPS, a bone awl for pedicle screw pilot hole drilling, the devicemaker said May 15. -
Stryker to lay off 500+ Florida employees
Stryker plans to lay off more than 500 employees by the end of December as it closes its Lakeland, Fla. facility, according to a WARN notice. -
Surgalign's Q1 revenue dips by $3.9M: 7 notes
Medical technology company Surgalign saw a $3.9 million dip in revenue in the first quarter of 2023 as compared with the same period last year, according to the company's first quarter financial report, released on May 11. -
NuVasive's Q1 sales grow 5.8 percent: 4 notes
NuVasive on May 10 posted first quarter sales of $307.7 million. -
Orthofix sees 65% revenue growth in Q1
Orthofix on May 9 posted $175.2 million in first quarter revenue. -
Intelivation Technologies launches minimally invasive screw system
Intelivation Technologies' Golden Isles minimally invasive screw system was launched, the devicemaker said May 9. -
Happe Spine's new interbody fusion system earns FDA nod
Happe Spine's Integrate-C interbody fusion system earned FDA 510(k) clearance, the devicemaker said May 8. -
Surgalign launches Holo AI Insights for neurovascular research
Surgalign launched Holo AI Insights for neurovascular research, the medtech company said May 8. -
Globus Medical's merger delayed: 3 earnings call notes
Globus Medical's planned merger with NuVasive will likely close in the third quarter of 2023 instead of mid-year, CEO Dan Scavilla said in a May 4 first quarter earnings call. -
Globus Medical sees 20% increase in Q1 sales: 4 notes
Globus Medical on May 4 posted first quarter sales of $276.7 million. -
OrthoPediatrics launches scoliosis system
OrthoPediatrics launched its Response Power system for scoliosis, the devicemaker said May 4. -
ZimVie sees 4.1% sales dip in Q1: 4 notes
ZimVie on May 3 posted net sales of $225.4 million in the first quarter of 2023. -
Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q1 2023
Stryker, Johnson & Johnson and Zimmer Biomet posted their first quarter financial results for 2023, and data on their orthopedic sales. -
Dr. Hunaldo Villalobos debuts WatchTower spine navigation system
Hunaldo Villalobos, MD, performed the first U.S. case with Captiva Spine's WatchTower spine navigation system, the medtech company said May 2. -
Stryker completes acquisition of neurosurgery company
Stryker has acquired Cerus Endovascular, the devicemaker said May 2. -
Aurora Spine's fiscal year 2022 sales grow 41.1%: 4 notes
Aurora Spine on May 1 posted its results for the fourth quarter and full year of fiscal year 2022.
Page 28 of 201